| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
From makeup and oils to capsules for stress relief, cannabis-based goods are flowing into the marketplace. But while they may not get you high, they can still cause you problems at work. Cannabidiol or CBD has been showing up in a widening array of goods. That's because federal legislation in 2018 deemed that hemp - one of its sources - was not an illegal controlled substance.
Employers must provide a safe work environment, and they want to ensure their employees are productive, but is maintaining a drug-testing program in furtherance of these goals worth the hassle? The answer may depend on the workplace.[CR-LF][CR-LF]"You have to consider the needs of the business, in addition to any applicable state laws," said Anne-Marie Welch, an attorney with Clark Hill in Birmingham, Mich. Some employers are federal contractors or hire drivers and have to follow specific drug-free workplace laws. Other employers are struggling to find qualified employees or want to maintain a certain culture and think that drug testing—particularly for marijuana—will hinder their ability to attract and retain talent.
LabCorp and Quest went into 2019 predicting some upsides to the Protecting Access to Medicare Act (PAMA), which is driving down how much Medicare pays for tests. The clinical laboratory leaders objected to the price cuts but felt they were better equipped to cope with them than smaller rivals, creating opportunities to consolidate the market.[CR-LF][CR-LF]However, the anticipated surge in acquisitions of local and hospital laboratories never materialized. Adam Schechter, who took over as CEO of LabCorp in November, discussed some reasons for lack of M&A activity during a presentation at the J.P. Morgan Healthcare Conference Tuesday.
Now that recreational pot is legal in Illinois, marijuana enthusiasts may feel like it’s finally time to emerge from hiding.[CR-LF][CR-LF]But people with jobs — or looking for them — might want to stay in the shadows for now as companies figure out how to handle employees who partake.
Medical companies that develop tests to diagnose neurological disorders, heart disease risk and fetal abnormalities have been in legal limbo since a 2012 Supreme Court ruling that limited the patenting of such tests, finding they occurred in nature and were not invented.[CR-LF][CR-LF]The high court may signal as soon as Friday whether it will revisit the subject as such tests become critical to the burgeoning field of personalized medicine, in which doctors determine whether a patient is genetically susceptible to a particular disease or would respond to certain treatments.
Quest Diagnostics Incorporated announced that it will report fourth quarter and full year 2019 results on Thursday, January 30, 2020, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day
PreemploymentDirectory.com, the background screening news and information portal for Human Resources professionals and Hiring Managers, has published an informative new guide on 'How to Select a Drug & Alcohol Screening Provider' to help employers select the right drug screening provider to meet their hiring needs at a time when drug use is on the increase.[CR-LF][CR-LF]The 'How to Select a Drug & Alcohol Screening Provider' guide was written specifically to help employers to select a drug testing provider who can meet their company's needs and to guide them in defining a successful program. Nina French, Managing Partner, Current Consulting Group, captures the intent of the Guide very well when she states, "Building a house relies on a good architect, a great contractor and excellent communication with the owner. Selecting the wrong vendors can be both expensive and frustrating. Likewise, a great substance abuse testing program takes great design, implementation and ongoing support. Understanding and translating your program design is key to building a successful partnership and selecting the right partner."
Blue Cross Blue Shield of Arizona (BCBSAZ), the state's largest locally based healthcare insurer, and Sharecare, the digital health company that helps people manage all their health in one place, today announced a strategic partnership to empower every Arizonan, regardless of insurance coverage, to improve their holistic health and well-being. Additionally, this deal provides exclusivity to BCBSAZ as the only Arizona-based health plan to offer the Sharecare platform to members or commercial customer groups.
The Federal Motor Carrier Safety Administration (FMCSA) announced December 27, 2019, that it is doubling the minimum annual percentage rate of random drug testing for commercial motor vehicle (CMV) drivers. The agency is raising the minimum random drug testing rate of commercial driver’s license (CDL) holders from the current 25 percent to 50 percent for calendar year 2020.
DNA testing kits were a popular gift over the holidays, and now one company is offering users the chance to learn more about their health as well as their past. NBC investigative and consumer correspondent Vicky Nguyen joins TODAY with what you need to know.
Hackers have accessed over 7.9 billion consumer records so far this year, with experts predicting that over 8.5 billion accounts will be exposed by the end of the year.[CR-LF][CR-LF]The majority of the over 5,000 data hacks this year Risk Based Security has tracked so far consisted of only a few million accounts. Yet there were a few mega hacks that involved hundreds of millions.[CR-LF]In early June, lab-testing company Quest Diagnostics announced that it found a data breach affecting its billing and collections vendor, the American Medical Collection Agency.
23andMe tests for 29 variants of the CFTR gene that causes cystic fibrosis, he said, while his department uses Quest Diagnostics to test for 161. Quest also offers a broader test that can look for about 1,000 variants associated with 98 percent of cystic fibrosis cases. More than 1,700 variants of this gene have been discovered, according to the CF Foundation.
With the possibility of legalizing recreational marijuana appearing on the 2020 ballot, the Florida House Health Quality Subcommittee continued hearings on the potential consequences of legalizing cannabis on Wednesday. [CR-LF] [CR-LF]Pro-legalization advocates have raised concerns that lawmakers have focused too much on the negatives and given little time to the positives.[CR-LF] [CR-LF]Members heard from economics professor Dr. Rosalie Pacula with the University of Southern California.[CR-LF]And a drug testing lab, which suggested its research shows employees have steadily been increasing marijuana use over the past decade.[CR-LF] [CR-LF]“There's been a 70 percent higher self-reported use of marijuana among those respondents not subject to employer drug testing,” said Dr. Barry Sample with Quest Diagnostics.
The laws about marijuana in Wisconsin aren't changing. But recent legalization of recreational marijuana in neighboring states and shifting societal norms are causing employers to rethink how to treat cannabis use. [CR-LF][CR-LF]Calls to MRA's human resources hotline about workplace drug testing increased in recent months. Employers are asking just how exactly the changing tides will affect them. [CR-LF][CR-LF]The laboratories that carry out employer-based drug testing, such as Quest Diagnostics, do not see evidence that people are abandoning the practice, said Quest Diagnostics Director of Science and Technology Barry Sample.
Quest Diagnostics Incorporated announced today the pricing of a public offering of $800 million aggregate principal amount of its 2.950% senior notes due 2030 under the Quest Diagnostics' shelf registration statement.
North Carolina’s governor has announced that a clinical trial lab services provider will add 749 jobs at a new facility over the next few years.[CR-LF][CR-LF]Gov. Roy Cooper issued a statement Wednesday that Q Squared Solutions LLC will invest $73 million in the Durham-based facility that’s expected to grow over seven years.The company is described as a joint venture between IQVIA and Quest Diagnostics that offers laboratory services and biospecimen management among other services.
For blockchain to be successful in healthcare, it needs to scale. This is why collaborations have been created between major healthcare organizations to grow the technology.[CR-LF][CR-LF]In April 2018, five healthcare giants — Humana, MultiPlan, Quest Diagnostics, UnitedHealthcare Group and Optum, launched the Synaptic Health Alliance, a pilot program using blockchain to ensure health plan provider directors include up-to-date physician information.[CR-LF][CR-LF]Since then, St. Louis-based Ascension and Aetna have joined the project.
As the United States tries to wean off prescription opioids, physicians worry about the impact on chronic pain patients: Doctors are concerned that many chronic pain patients will turn to illicit drugs if they do not have access to prescription opioids, according to a new report from Quest Diagnostics. For the report, researchers polled 500 primary care physicians (PCPs) and analyzed 4.4 million lab test results.
Stewardship is defined as “the careful and responsible management of something entrusted to one's care.” In health care, laboratory administrators are frontline stewards, providing quality, appropriate laboratory services to guide patient care. [CR-LF][CR-LF]But laboratory administrators are increasingly in charge of a different kind of stewardship—managing the cost of laboratory spend and achievement of financial incentives for meeting lab-based quality metrics. That’s because laboratory testing drives most health care decisions, with significant downstream consequences on patient outcomes and costs.
Robotic process automation (RPA), or bots that can be programmed to perform tedious and mundane tasks, is undergoing a period of explosive growth. Deloitte reports that 53% of companies have begun deploying it and that 78% of adopters will invest more in RPA in the next three years. In fact, assuming the current trend continues, it’s anticipated that RPA will achieve “near universal adoption” within five years.[CR-LF][CR-LF]One of the incumbents in the space is Automation Anywhere, which in the roughly 16 years since its founding has attracted over 3,500 customers in more than 90 countries, among them LinkedIn, MasterCard, Comcast, Hitachi, Stanley Black & Decker, IBM, Cisco, Symantic, Juniper Networks, Tesco, Unilever, Volkswagen, Whirlpool, Quest Diagnostics, Deloitte, Boston Scientific, Dell EMC, Accenture, Cognizent, Siemens, PricewaterhouseCoopers, and the World Bank.
Among more than 100,000 patients enrolled in both commercial insurance and Medicare Advantage programs, researchers found that the annual percentage undergoing tapering doubled between 2008 and 2017.[CR-LF][CR-LF]In another recent survey, which was conducted by Quest Diagnostics and the Center on Addiction, more than four out of five doctors said they were reluctant to take on patients using prescribed opioids. They also said the opioid crisis made it more difficult to treat patients in pain.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Neither vitamin D nor marine omega-3 (n-3) fatty acid supplementation significantly reduces the rate of first heart failure hospitalization, according to a research letter published online Nov. 11 in Circulation to coincide with the annual meeting of the American Heart Association, held from Nov. 16 to 18 in Philadelphia.[CR-LF][CR-LF]Luc Djoussé, M.D., Sc.D., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues examined the effects of vitamin D and n-3 supplements on the incidence of heart failure hospitalization in a large, multi-ethnic cohort with 25,871 adults; 36 participants with prevalent heart failure were excluded.[CR-LF]Two authors disclosed financial ties to Quest Diagnostics, which measured serum 25-hydroxyvitamin D and serum omega-3 index at no cost; several pharmaceutical companies provided the study agents, matching placebos, and packaging.
A laboratory test that evaluates high-density lipoprotein (HDL) cholesterol function provides unique and novel information for assessing cardiovascular disease risk, according to data presented today (Abstract #1020) by Quest Diagnostics (NYSE: DGX) at the 2019 American Heart Association Scientific Sessions. The study is one of four the company will present at the conference, which runs November 16-18, in Philadelphia (Booth #1502).
Technology’s role in health care is creating new opportunities for established health care providers and insurers, as well as entrepreneurs.[CR-LF][CR-LF]That was the conclusion of a panel of health care experts at the Newark Regional Business Partnership series entitled: How Technology is Changing Health Care on Thursday in Newark.[CR-LF]Dr. Damian Alagia, chief clinical officer, Health Systems at Quest Diagnostics said that for an entrepreneur it is a great time to be in medicine.[CR-LF][CR-LF]“Anyplace in health care where you can put the patient in the center of everything you can do … if you look at health systems and doctors offices that are successful, they are the ones that kept the patients at the center, everything emanates from that patient care model. If you get that right everything else falls into place,” said Alagia.